Amneal Pharmaceuticals, Inc. - News - Press Releases

2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002

Nov 20, 2014

Amneal Launches AG for Novo Nordisk’s ACTIVELLA®

Nov 10, 2014

Impax Laboratories to Present at the 2014 Credit Suisse Healthcare Conference on November 11

Nov 06, 2014

Impax Submits Marketing Authorization Application to EMA for IPX066 (Carbidopa-Levodopa) Extended-Release Capsules

Nov 04, 2014

Impax's Third Quarter 2014 Revenues Increased 19% to $158 Million

Oct 30, 2014

Impax Announces R&D Reorganization Designed to Yield Process Improvements and Efficiencies

Oct 27, 2014

Amneal Execs Receive Long Island Cares Humanitarian Award

Oct 24, 2014

Amneal‘s Candis Edwards to Present at 2014 GPhA Fall Technical Conference

Oct 22, 2014

Impax Announces Departure of Carole Ben-Maimon, M.D., President of Global Pharmaceuticals

Oct 21, 2014

Amneal Wins Generics Bulletin “Company of the Year” Award

Oct 09, 2014

Impax To Acquire Tower Holdings, Inc. And Lineage Therapeutics Inc.

Oct 07, 2014

Impax Laboratories to Announce Results for Third Quarter 2014 on November 4

Sep 29, 2014

Pharma Equities Technical Momentum - Provectus Biopharma, Shire, Impax Labs, Zogenix, and TherapeuticsMD

Sep 23, 2014

Amneal Undertakes Major Sales & Distribution Expansion in KY

Sep 17, 2014

Impax Pharmaceuticals Announces Extension of RYTARY™ FDA Review Date to January 9, 2015

Sep 12, 2014

SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action against Impax Laboratories, Inc. and Certain Officers - IPXL

Aug 15, 2014

Amneal Launches Four New Generics

Aug 06, 2014

Impax's Second Quarter 2014 Revenues Increased 45% to $188.1 Million

Aug 04, 2014

FDA Performs Inspection of Impax's Hayward Facility

Jul 29, 2014

FDA Performs Inspection of Impax's Taiwan Facility

Jul 02, 2014

Impax Acquires Two Products from Actavis

Jul 01, 2014

Impax Laboratories to Announce Results for Second Quarter 2014 on August 6

Jun 06, 2014

Impax to Present at Goldman Sachs 35th Annual Global Healthcare Conference

May 30, 2014

NJCU to Honor Pharma Giant Chirag Patel

May 12, 2014

Impax Laboratories to Present at Upcoming Investor Conferences

May 01, 2014

Impax Laboratories Reports First Quarter 2014 Results

Apr 21, 2014

Impax Board of Directors Appoints G. Frederick Wilkinson President and CEO

Apr 16, 2014

Impax Launches Authorized Generic RENVELA®

Apr 11, 2014

Impax Pharmaceuticals Resubmits New Drug Application for RYTARY™ (Carbidopa and Levodopa) Extended-Release Capsules (IPX066)

Apr 07, 2014

Impax Laboratories Schedules Conference Call and Webcast for First Quarter 2014 Financial Results

Apr 02, 2014

Impax Laboratories Announces the Alignment of Quality and Manufacturing Operations Under the Leadership of Jeffrey D. Nornhold

Feb 26, 2014

Impax Laboratories to Present at the Cowen and Company 34th Annual Health Care Conference

Feb 20, 2014

Impax Laboratories Reports Fourth Quarter and Full Year 2013 Results

Jan 24, 2014

Impax Laboratories Schedules Conference Call and Webcast for Fourth Quarter and Full Year 2013 Financial Results

Jan 14, 2014

Impax Laboratories Provides Financial Outlook for 2014

Jan 10, 2014

Drugmakers to FDA: Can you speed it up? Amneal, providers paying the price of approval backlog

Jan 09, 2014

Amneal Appoints Rochelle Fuhrmann New Chief Financial Officer

Jan 07, 2014

Impax Laboratories to Present at the 32nd Annual J.P. Morgan Healthcare Conference

Jan 07, 2014

Impax and DURECT Sign a $63 Million Agreement to Develop and Commercialize DURECT’s ELADUR® Pain Patch

Jan 06, 2014

Amneal Announces Launch of Esomeprazole Strontium 49.3 mg Delayed-Release Capsules Authorized Generic

© Amneal Pharmaceuticals LLC.

All rights reserved.

Powered By Q4 Inc. 5.15.0.14